These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30841723)

  • 1. Trends and Implications of DF-4 Implantable Cardioverter-Defibrillator Lead Adoption in the United States of America.
    Li JZ; Bhonsale A; Estes NAM; Jain SK; Kancharla K; Mezu-Chukwu U; Saba S; Shalaby AA; Voigt AH; Wang NC
    Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007134. PubMed ID: 30841723
    [No Abstract]   [Full Text] [Related]  

  • 2. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
    Kramer DB; Normand ST; Volya R; Hatfield LA
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
    Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
    Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary trends and factors associated with use of subcutaneous versus transvenous implantable cardioverter-defibrillator therapy.
    Shatla I; Mehta N; Kennedy KF; Elkaryoni A; Wimmer AP
    Europace; 2024 Jul; 26(7):. PubMed ID: 38902965
    [No Abstract]   [Full Text] [Related]  

  • 6. Questionnaire in patients with aborted sudden cardiac death due to coronary spasm in Japan.
    Sueda S; Shinohara T; Takahashi N; Shite J; Shoji T; Akao M; Kijima Y; Masuyama T; Miyaji T; Yamamoto K; Iwasaki Y; Yoshida R; Nakamura S; Ogino Y; Kimura K; Sasai M; Suzuki H; Wakatsuki T; Asajima H; Teragawa H; Ishikawa T; Kitamura K; Oda T; Nakayama T; Kobayashi Y; Sunada D; Yamaki M; Nishizaki F; Tomita Y; Usuda K; Fujinaga H; Kuramitsu S; Andou K; Kiyooka T; Kadota K; Ishii Y; Ohtani H; Maekawa Y; Taguchi E; Nakao K; Kobayashi N; Seino Y; Nakagawa H; Saito Y; Komuro I; Sasaki Y; Ikeda S; Yamaguchi O; Kakutani A; Imanaka T; Ishihara M; Ishii M; Kaikita K; Tsujita K
    Heart Vessels; 2020 Dec; 35(12):1640-1649. PubMed ID: 32533313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association.
    Raatikainen MJP; Arnar DO; Merkely B; Nielsen JC; Hindricks G; Heidbuchel H; Camm J
    Europace; 2017 Aug; 19(suppl_2):ii1-ii90. PubMed ID: 28903470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates.
    Chui PW; Wang Y; Ranasinghe I; Mitiku TY; Seto AH; Rosman L; Lampert R; Minges KE; Enriquez AD; Curtis JP
    Circ Cardiovasc Qual Outcomes; 2019 Jun; 12(6):e005374. PubMed ID: 31185734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice.
    Boveda S; Narayanan K; Jacob S; Providencia R; Algalarrondo V; Bouzeman A; Beganton F; Defaye P; Perier MC; Sadoul N; Piot O; Klug D; Gras D; Fauchier L; Bordachar P; Babuty D; Deharo JC; Leclercq C; Marijon E;
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):666-673. PubMed ID: 28251724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender, Racial, and Health Insurance Differences in the Trend of Implantable Cardioverter-Defibrillator (ICD) Utilization: A United States Experience Over the Last Decade.
    Patel NJ; Edla S; Deshmukh A; Nalluri N; Patel N; Agnihotri K; Patel A; Savani C; Patel N; Bhimani R; Thakkar B; Arora S; Asti D; Badheka AO; Parikh V; Mitrani RD; Noseworthy P; Paydak H; Viles-Gonzalez J; Friedman PA; Kowalski M
    Clin Cardiol; 2016 Feb; 39(2):63-71. PubMed ID: 26799597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry.
    Valzania C; Gadler F; Boriani G; Rapezzi C; Eriksson MJ
    Scand Cardiovasc J; 2020 Aug; 54(4):239-247. PubMed ID: 32054352
    [No Abstract]   [Full Text] [Related]  

  • 12. Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey.
    Boveda S; Lenarczyk R; Haugaa K; Fumagalli S; Madrid AH; Defaye P; Broadhurst P; Dagres N
    Europace; 2016 Sep; 18(9):1434-9. PubMed ID: 27582309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troubleshooting implanted cardioverter defibrillator sensing problems I.
    Swerdlow CD; Asirvatham SJ; Ellenbogen KA; Friedman PA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1237-61. PubMed ID: 25516582
    [No Abstract]   [Full Text] [Related]  

  • 14. Troubleshooting implantable cardioverter-defibrillator sensing problems II.
    Swerdlow CD; Asirvatham SJ; Ellenbogen KA; Friedman PA
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):212-20. PubMed ID: 25691555
    [No Abstract]   [Full Text] [Related]  

  • 15. Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases.
    Banks H; Torbica A; Valzania C; Varabyova Y; Prevolnik Rupel V; Taylor RS; Hunger T; Walker S; Boriani G; Fattore G;
    Europace; 2018 Apr; 20(4):643-653. PubMed ID: 29016747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-of-life of implantable defibrillator: are we certain it should always be replaced?
    Stazi F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158
    [No Abstract]   [Full Text] [Related]  

  • 17. The story of … a lead.
    Nisam S; Reddy S
    Europace; 2015 May; 17(5):677-88. PubMed ID: 25755290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; Mcguire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S;
    Europace; 2016 Feb; 18(2):159-83. PubMed ID: 26585598
    [No Abstract]   [Full Text] [Related]  

  • 19. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 20. A New Riata Lead Complication: Spontaneous Lead Tip Embolization.
    Nadeau PL; Philippon F; Sarrazin JF; Champagne J
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):234-5. PubMed ID: 26331700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.